Mode of action of psilocybin

Presented By
Prof. Scott Thompson, University of Colorado School of Medicine, CO, USA
Conference
ECNP 2022

Dapagliflozin DELIVERs for HFmrEF/HFpEF

Presented By
Prof. Scott Solomon, Brigham and Women's Hospital, Harvard Medical School, MA, USA
Trial
Phase 3, DELIVER
Conference
ESC 2022

Smartphones for AF detection

Presented By
Prof. Axel Bauer, Innsbruck Medical University, Austria
Trial
eBRAVE-AF
Conference
ESC 2022

Advance care planning

Presented By
Prof. Mette Asbjørn Neergaard, Aarhus University, Denmark & Dr Reeta Piili, Tampere University, Finland
Conference
NLC 2022

CRSwNP outlined

Presented By
Dr Sanna Toppila-Salmi, University of Helsinki, Finland
Conference
NLC 2022

COVI-PRONE trial on its back

Presented By
Prof. Waleed Alhazzani, McMaster University, Canada
Trial
COVI-PRONE
Conference
ATS 2022

Surprise outcome for SODIUM-HF

Presented By
Prof. Justin Ezekowitz, University of Alberta, Canada
Trial
Phase 3, SODIUM-HF
Conference
ACC 2022

Positive outcomes for etrasimod in UC

Presented By
Prof. William J Sandborn, University of California San Diego, CA, USA
Trial
Phase 3, ELEVATE UC 12; ELEVATE UC 52
Conference
DDW 2022

Letter from the Editor

Editor
Prof. Hans-Peter Hartung, Heinrich-Heine-University Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Medical University of Vienna, Austria; Palacky University Olomouc, Czech Republic
Conference
AAN 2022

Rare EGFR mutations as oncogenic drivers

Presented By
Dr Alfredo Addeo (University Hospital of Geneva, Switzerland) and Dr Giulia Pasello (Veneto Institute of Oncology, Italy)
Conference
ELCC 2022

Darolutamide improves OS in mHSPC

Presented By
Dr Matthew Smith, Massachusetts General Hospital Cancer Center, MA, USA
Trial
Phase 3, ARASENS
Conference
ASCO GU 2022